Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma: An update

W. L. White, B. W. Loggie

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

The management of lymph nodes in melanoma patients who have no clinical evidence of nodal disease has changed dramatically with the development of selective lymph node biopsy. This procedure localizes the node in a regional basin most likely to contain a metastasis (the sentinel node) and averts the morbidity of unnecessary elective node dissection. This update reviews the rationale for this procedure and describes the methodology used by the surgeon and the pathologist. A progress report highlights the promise and limitation of this procedure. Sentinel node biopsy is currently the standard for staging select groups of melanoma patients, but the field is rapidly evolving and may eventually be surpassed by even newer molecular diagnostic techniques.

Original languageEnglish (US)
Pages (from-to)645-655
Number of pages11
JournalDermatologic Clinics
Volume17
Issue number3
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint Dive into the research topics of 'Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma: An update'. Together they form a unique fingerprint.

  • Cite this